Key result
COPD was associated with a significantly higher frequency of psychiatric comorbidities compared to controls (28.4% vs 2.7%; P<0.05).
Why the study?
Is the frequency of psychiatric comorbidities increased in COPD patients compared to controls?
Case-Control (n=148)
No
Is the frequency of psychiatric comorbidities increased in COPD patients compared to controls?
Absolute Event Rate: 28.4% vs 2.7%
p-value: p=<0.05
Psychiatric comorbidities are significantly more common in COPD patients, particularly those with severe disease or longer symptom duration, highlighting the need for routine screening.
Psychiatric comorbidities were associated with COPD; leaves open whether screening improves outcomes in this population.
INTRODUCTION: Psychiatric disorders, especially anxiety and depression have been reported to have an increased prevalence in chronic obstructive pulmonary disease (COPD) patients, but there is a paucity of data from India. AIMS AND OBJECTIVES: Aim of our study is to study the frequency of psychiatric comorbidities in COPD patients and their correlation with severity of COPD, as per global initiative for obstructive lung disease guidelines. MATERIALS AND METHODS: This study was conducted in outpatient department of a tertiary care hospital (King George's Medical University). A total of 74 COPD patients were included in this study and compared with 74 controls. The diagnosis and severity of COPD were assessed by spirometry. Psychiatric comorbidities were assessed using the Mini International Neuropsychiatric Interview questionnaire. RESULTS: The frequency of psychiatric comorbidities was significantly higher (P < 0.05) in COPD patients (28.4%) as compared to controls (2.7%). As regards to severity, the frequency was significantly increased in severe and very severe COPD. The frequency of psychiatric comorbidities in COPD patients increased significantly with the increase in duration of symptoms being present in 67% of patients with duration of symptoms more than 10 years and only 23% of patients with duration of symptoms ≤5 years. CONCLUSION: The frequency of psychiatric comorbidities is increased in COPD patients as compared to controls. We recommend that all patients with COPD should be screened for psychiatric comorbidity, if any.
No takes yet. Share an insight, caveat, or question.
Nanda et al. (2016) conducted a case-control in Chronic obstructive pulmonary disease (COPD) (n=148). Chronic obstructive pulmonary disease vs. Controls was evaluated on Frequency of psychiatric comorbidities (p=<0.05). COPD was associated with a significantly higher frequency of psychiatric comorbidities compared to controls (28.4% vs 2.7%; P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: